In Reply to Morris and Tyldesley

To the Editor: We thank Drs Morris and Tyldesley for pointing out our error in reporting the results of the ASCENDE-RT trial (1, 2). When reading the abstract (3) we were mistaken in reading the "Results" section. Specifically, the results reporting begins with reference to biochemical failure scored via the Phoenix definition (4) and then proceeds to report specific percentages using a 0.2-ng/mL threshold definition. We made an error in assuming that the entire reporting of biochemical results was according to the definition mentioned in the initial sentences.

http://ift.tt/2vvtAoM